Members area login




Please enter your email address


Please enter your membership ID (optional)

Follow Cephalalgia
Follow IHS

Board & committees

Board of Trustees

The 12 members of the Board of Trustees include the four Officers of the Society (President, President-elect, Treasurer and Secretary). The President, President-elect and six Trustees are elected by the membership; three Trustees are appointed to add under-represented perspectives and/or specific expertise to the Board. The elected members are elected to 2-year terms of office by the membership during the AGM held during the International Headache Congress, automatically renewable for a second 2-year term. Any standard member of the Society may be nominated to join the Board of Trustees. Additional Trustees can be Co-opted by the Board to serve a 2-year term.

Standing Committees and Special Interest Groups

The Society's 20 Standing Committees and Special Interest Groups each have a specific role and advise the Board of Trustees on particular aspects of the business and/or functions of the Society. Each has a Chairman appointed by the Board of Trustees who must be a member of the Society. There are standing and ad-hoc Standing Committees. Both have prescribed areas of responsibility, standing committees remaining permanently in place with continuous activities or functions, ad-hoc being reconstituted from time to time to carry out particular initiatives. The Linguistic Special Interest Groups have more general responsibility for promoting the Society's objectives amongst those whose first language is not English. Click on the individual Committees in the menu below for details of each Committee's aims and activities together with the names and contact details of the Chairmen and members.

Select individual committees from the drop-down menu for remit, members and activitites.

Advisory Council

The Advisory Council is comprised of the Chairmen of the Standing Committees and Special Interest Groups and the elected representatives of member National Societies. The Advisory Council meets annually to report their activities and give advice to the Board of Trustees. 

Task Forces

The Board of Trustees and Standing Committees can create Task Forces as required to undertake specific one-off time-limited activities.


Select from the drop down menu:

Board of trustees


  • Lars Edvinsson (Sweden)
    Institution: University Hospital of Lund
    Country: Sweden

    Lars Edvinsson is currently Professor and senior consultant at Lund University/Hospital in Internal Medicine, MD DMSci, and Chairman of the Swedish Migraine Society. He has served on the Board of the European Headache Federation until 2016.

    In 2008 Lars Edvinsson was called to be professor at the Copenhagen University in "Receptor Regulation in Cerebrovascular and Cardiovascular Diseases" and in 2007 was Founder, and is now Director, of the Glostrup Research Park, Copenhagen. In 2012 he received a Lifetime Achievement award from American Headache colleagues (Stowe, VT), and an Honoray Dr Hon Causa in Szeged, Hungary.

    He has a long history in studies of the cerebral circulation, innervation, receptors and function. In 1984 He was the first to describe CGRP in cranial vessels and the trigeminal ganglion, showed the release of CGRP in conjunction with migraine and cluster headache attacks, and has been instrumental in the development of novel CGRP receptor antagonists. His current work is centered at finding localisation of CGRP receptors in cranial structures and in CNS in order to illustrate the possible sites of action of novel CGRP acting drugs. The work involves also studies of other possible migraine candidates such as PACAP and 5-HT subtype receptor expressions as well as studies of their interactions and functional roles.

    Consulted for AMGEN/Novartis and TEVA pharma in terms of giving advice and received support for basic studies.


  • Messoud Ashina (Denmark)
    Institution: Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen
    Country: Denmark

    Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He is also Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.

    Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, functional neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of antimigraine medications. He has authored over 400 papers, abstracts and book chapters on the topic of headache, including migraine.

    Associate Editor of Cephalalgia and Co-Editor of Journal of Headache and Pain.
    Consulting: Alder, Allergan, Amgen, Alder, ATI, Eli Lilly, Novartis and Teva
    Principal investigator: Alder ALD403-CLIN-011 (Phase 3b), Amgen 20120178 (Phase 2), 20120295 (Phase 2), 20130255 (OLE), 20120297 (Phase 3), GM-11 gamma-Core-R trials, Novartis CAMG334a2301 (Phase 3b), and PAC1 20150308 (Phase 2a)

Honorary Secretary:

  • Stefan Evers (Germany)
    Institution: University of Münster and Krankenhaus Lindenbrunn
    Country: Germany

    Stefan Evers received his MD in medicine and his PhD in musicology at the University of Münster, Germany. After training in general neurology including 1 year of research at the Institute of Neurology, London, he became consultant and Professor of Neurology at the Department of Neurology, University of Münster. In 2012 he became Head of the Neurological Hospital "Lindenbrunn".

    Stefan Evers was President of the German Migraine and Headache Society from 2003 to 2007 and Chair of the Headache Panel of the European Federation of Neurological Societies from 2003 to 2010. Since 2015 he is Chair of the Headache Panel of the European Academy of Neurology. Since 2011 he has been Honorary General Secretary of the IHS.

    He has published more than 220 scientific papers and several book chapters and books on headache and migraine, pain research, and general clinical neurology. Besides pain, special fields of interest are epilepsy, stroke, neuromanifestations of HIV infection, and the neurobiology of music.

    Honoraria for consulting: Allergan; Reckitt Benckiser; Johnson & Johnson; Amgen; Novartis
    Speaker's honoraria: Allergan; Reckitt Benckiser; Mundipharma; Pfizer; Menarini; Novartis

Honorary Treasurer:

  • Wendy Thomas (UK)
    Country: UK

    Wendy Thomas is past Chief Executive of The Migraine Trust, the health and medical research charity for migraine in the United Kingdom. She is also a director and chair of the Migraine Trust International Symposium  Ltd. (appointed by The Migraine Trust), 

    She is currently Treasurer of the British Association for the Study of Headache (BASH).

    Ms Thomas' interests have been in charity governance and in particular the importance of the control of financial aspects of the organisation concerned. She works to ensure that the finances of IHS are on a sound footing and stay that way, and aims to make the finances to be transparent and therefore easy for the non-financial mind to understand.

    Treasurer of British Association for the Study of Headache; Director and chair of the Migraine Trust International Symposium Ltd.

Past president:

  • David William Dodick (USA)
    Institution: Mayo Clinic
    Country: USA

    David W Dodick, MD, FRCP (C), FACP, is Professor of Neurology at the Mayo Clinic College of Medicine and a consultant in neurology at the Mayo Clinic, in Scottsdale, Arizona. He is the Director of the Headache Program and the Sports Neurology and Concussion Program at Mayo Clinic in Arizona. Dr Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology.

    Dr Dodick has authored more than 350 peer-reviewed publications and authored/edited 10 books. He is the Chair of the Sports Concussion Conference Workgroup and the AAN Annual Sports Concussion Conference of the American Academy of Neurology and a member of the AAN’s Annual Meeting Committee. He is a member of the scientific committee of the International Migraine Trust. He is Chair of the International Headache Academy. He is on the editorial board of several journals including Lancet Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Postgraduate Medicine, Headache, and Cephalalgia.

    He is the immediate Past-President of the International Headache Society, Past President of the American Headache Society, Chair of the American Migraine Foundation, Director of the US Academic Headache Consortium, and past-Editor-in-Chief of Cephalalgia.

    Consulting: Acorda, Allergan, Amgen, Alder, Promius, eNeura, Eli Lilly & Company, Insys therapeutics, Autonomic Technologies, Teva, Xenon, Tonix, Trigemina, Boston Scientific, GBS, Colucid, Zosano, Laydenburg Thalmann, Biocentric, Biohaven, Magellan, Charleston Laboratories, Theranica.
    Royalties: Oxford University Press and Cambridge University Press (Book Royalty).
    Editorial/honoraria from UpToDate, Chameleon Communications, Medscape, WebMD, Academy for Continued Healthcare Learning, Haymarket Medical Education, Global Scientific Communications, HealthLogix,
    Academy for Continued Healthcare Learning, MeetingLogiX, Wiley Blackwell, Oxford University Press, Cambridge University Press. Stock/options: GBS/Nocira, Epien, Healint, and Mobile Health. Consulting use
    agreement: NAS. Board position: King-Devick Inc.

Elected Trustees:

  • Anna Ambrosini (Italy)
    Institution: IRCCS Neuromed
    Country: Italy

    Born in Rome (Italy) on 1965. MD in 1990, Specialist in Neurology in 1994, PhD in Neurophysiology in 2000 at the University “La Sapienza” of Rome.

    Research Assistant (1998–2000) at the University Dept Neurology of Liège with Prof. J. Schoenen. Clinical Consultant- Scientific Researcher  since

    2001 at the Headache Clinic, and since February 2013 Head of the Headache Medicine Dept in the IRCCS “Neuromed” in Pozzilli (Isernia, Italy). Granted with IHS-GSK PPA Humphrey International Fellowship 2002.

    Member of the International Headache Society since 2001.Junior Secretary of the Scientist Panel on Headache of  European Federation of Neurological Societies (1998-2000). Member of the Italian Headache Society (SISC) since 2001, where she served as President of the Inter-Regional Section Lazio-Molise (2007-2010), National Delegate to the European Headache Federation  (2009-2012) and Treasurer (2013-2016).  She published  up to now one book,  5 book chapters, 50 articles. Her H-index, at the present, is 24.


  • Rigmor Jensen (Denmark)
    Institution: Danish Headache Center, University of Copenhagen
    Country: Denmark

    Rigmor Højland Jensen is specialized in Neurology and professor in headache and neurological pain at The University of Copenhagen and the director of The Danish Headache Center, Glostrup Hospital. She is past-president of The European Headache Federation, director in Lifting The Global Burden of Headache.   
    Born in Denmark in 1954. Medical Degree from University of Copenhagen 1981. Specialist in Neurology.
    Fellowship at The Headache Clinic in Gentofte Hospital under supervision of Professor Jes Olesen, and received a doctoral degree from University of Copenhagen in 1999.
    Has conducted or otherwise been involved in numerous epidemiological, clinical, and neurophysiological studies of migraine and tension-type headache since 1988.
    Co-founder and now director of The Danish Headache Center, a multidisciplinary academic headache center, at Rigshospitalet-Glostrup, awarded as Global Excellence in Health in 2010 and 2014.
    Has published more than 300 scientific papers in peer-refereed journals, edited 2 textbooks and authored more than 50 chapters in text books.
    Present areas of research: Management of headache, CSF-physiology, Pain mechanisms and epidemiology, Medication overuse headache, Tension-Type Headache  and Cluster headache.
    Has been working extensively with national and international organisation of headache care, pre- and postgraduate education in headache since 1988.
    Has most recently initiated and directed an international  university degree in headache disorders, The Master in Headache Disorders at University of Copenhagen ( The program started in 2016 and the first 18 candidates will graduate in June 2018.
    Aims to contribute to IHS with a detailed knowledge of global headache care and research, and an extensive international network. I also aim to expand the present IHS-activities within education and politics for an equal and better global access to headache care.

    Rigmor Højland Jensen has given lectures for, conducted clinical trials and received honoraria from Allergan, Pfizer, Autonomic Technologies, ElectroCore, Berlin Chemie and Eli-Lilly.

  • Mario Peres (Brazil)
    Institution: Sao Paulo Headache Center
    Country: Brazil

    Mario F P Peres, MD, PhD, FACP, is the Founder of the São Paulo Headache Center and Program Director of the Headache Medicine training for the Neurology Residency Program at Albert Einstein Hospital in São Paulo, Brazil. Senior Researcher and Professor of Postgraduation at Albert Einstein Hospital and at Psychiatry Institute, São Paulo State University Medical School. Born in São Paulo in 1971, had neurology residency training in 1998, PhD in Neurology in 2000 at Federal University of São Paulo, Headache Fellowship at Jefferson Headache Center, Thomas Jefferson University in 2000-2001.
    Dr Peres has authored and/or co-authored more than 130 peer-reviewed publications, book chapters, and a book to headache patients. He has been dedicated the past 15 years full time to the headache field, in clinical practice, academic training, public awareness and research. Developed a headache medicine E-learning program for health professionals, a headache diary app, and internet content with more than 10 million individual page views in the past years.

    He has been served as member of several committees at the Internation Headache Society and Brazilian Headache Society, currently part of the Ethics Committee, Cluster Headache Study Group, Headache Classification working group.
    Research Grants : Fapesp, Cnpq, Natura

  • Patricia Pozo-Rosich (Spain)
    Institution: University Hospital Vall d Hebron
    Country: Spain

    Patricia Pozo-Rosich, MD PhD, is a specialist in neurology, and is currently in charge of the Headache and Neurological Pain Clinical Unit at the University Hospital Vall d’Hebron, Barcelona, Spain, and the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which is a part of the Autonomous University of Barcelona.

    After winning the La Caixa and AHS awards, she became a Fellow in Basic Research, first with Professor Stephen Silberstein at the Thomas Jefferson University, PA, US, and subsequently, collaborated with Professor Peter Goadsby on research projects at both the University College London, UK, and the University of California San Francisco, CA, US.

    Dr Pozo-Rosich’s research focuses on improving the quality of life of patients suffering from headache by increasing our understanding of headache pathophysiology. In her role as a member of the International Headache Genetics Consortium, she has been involved in numerous projects on the genetics of migraine. She has received funding from the Fondo de Investigaciones Sanitarias (ISCIII), the La Marató de TV3 Foundation, the Migraine Research Foundation and la Caixa Foundation, to develop translational research projects. Her clinical research experience includes participating as a principal investigator in phase II, III and IV trials.

    She has directed PhD students and teaches residents, students, neurologists and other physicians. She is a professor in the Translational Research Master at the VHIR.

    She is a member of the International Headache Society, where she is a member of the Clinical Trials Guidelines Committee and the IHS Women’s Leadership Forum. She is also a member of the American Headache Society. She is the past-president of the Headache Study Group of the Spanish Neurological Society (

    She is the Editor for Headache in Revista de Neurologia, Associate Editor for Frontiers in Neurology – Headache Section- and the Journal of Headache and Pain. She has published  original and review papers, , book chapters, and edited several National Guidelines, authored a book and launched the website for the Headache Spanish speaking community focused both on patients and physicians.
    Consulting, Educational and Speaker fees: Allergan,Almirall, Chiesi, Eli Lilly, Novartis, Teva


  • Todd Schwedt (USA)
    Institution: Mayo Clinic
    Country: USA

    Todd Schwedt, MD, MSCI is a Professor of Neurology and Chair of Neurology Research at the Mayo Clinic Arizona.  In addition to his clinical duties in the Mayo Headache Clinic, he leads an active headache research portfolio.  He is a principal investigator of the Neuroimaging of Headache Laboratory at Mayo Clinic, of the American Registry for Migraine Research (ARMR), the Medication Overuse Treatment Strategy Trial (MOTS), and he is the Medical Director of the Mayo Clinic Arizona Clinical Studies Unit. He was a recipient of the 2015 Harold G. Wolff Award from the American Headache Society, an award presented annually to a researcher who has most significantly contributed to the understanding of headache. Dr. Schwedt serves on the Board of Directors for the American Headache Society, is a member of the American Headache Society scientific meeting planning committee, is the chairperson of the post-traumatic headache working group for the International Classification of Headache Disorders, and is an associate editor for Cephalalgia, Headache, Headache Currents and Pain Medicine. Dr. Schwedt is a frequent lecturer and has authored over 100 peer-reviewed publications.

    Research Funding: National Institutes of Health (NIH); Department of Defense (DOD); Mayo Clinic / Arizona State University; American Migraine Foundation; Patient Centered Outcomes Research Institute (PCORI). Consulting: Allergan; Amgen; ATI; Avanir; Dr. Reddy’s; GBS; Novartis; Second Opinion; Supernus; Teva. Options: GBS; Second Opinion.

  • Gisela M Terwindt (Netherlands)
    Institution: Leiden University Medical Centre
    Country: Netherlands

    Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is associate professor of Neurology, and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands, where she also runs the Headache Clinic.

    Gisela Terwindt is chair of the scientific committee of the Dutch Headache Society. She is member of the International Headache Classification Committee, the IHS Ethics Committee, and chair of the IHS Women’s Leadership Forum.

    She has published >150 scientific papers and several book chapters on headache and migraine.  She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI-award).


    Gisela Terwindt reports  independent support from NWO, European Community, and the Dutch Heart Foundation.

Ex-officio Trustee:

  • Arne May (Germany)
    Institution: Universitäts-Krankenhaus Eppendorf (UKE)
    Country: Germany

    Arne May is a Professor of Neurology in the Department of Systems Neuroscience at the University of Hamburg and head of the headache outpatient clinic and the facial outpatient clinic of the University clinic of Hamburg. His major research interests are the basic mechanisms of facial and headpain, the chronification of pain and plasticity within the human brain. The work of his group involves human imaging studies in primary headache as well as experimental studies of trigeminovascular nociception, with the aim of understanding how to modulate facial and headache syndromes and chronicity of pain. Prior to his position at the University of Hamburg, Professor May was a clinician and conducted research into pain and headache syndromes at the University of Regensburg. Prior to this he completed his residency in the Neurology Department of the University of Essen, followed by post-doctorate studies at the Institute of Neurology in London. Professor May is currently a member of the Board of trustees of the International Headache Society since 2013. He has published around 300 original and review articles with an h-index of 66 and is since 2016 the Editor of Cephalalgia.

    Dr May receives his salary from the University Clinic of Hamburg and received research funds by the Deutsche Forschungsgemeinschaft (DFG, SFB936) and the European Union (FP7), a unrestricted research fund from Chordate Medical and until December 2015 has been consultant or speaker for Allergan, ATI, TEVA, Electrocore, and Desitin. Since 2016 he is Editor in Chief for Cephalalgia. 

  • Allan Purdy (Canada)
    Institution: Dalhousie University
    Country: Canada

    R Allan Purdy MD, FRCPC, is Professor of Medicine (Neurology) at Dalhousie University. He was Professor and Head of the Department of Medicine, and Chief of the Medicine Service of the Department of Medicine at Dalhousie and Capital Health from 2005 to June of 2011. He is a Fellow of the Royal College of Physicians of Canada, and was elected a Fellow of the American College of Physicians in 2008. He previously was the Professor and Head of Neurology at Dalhousie from 1994 to 2006. He is a Fellow of the American Headache Society in 2010 and is the President of the American Headache Society.  

    Dr. Purdy is Past-President of the Canadian Headache Society. He is the Chair of the Education Committee of the International Headache Society and is on the Board of Directors of the both societies. He directs headache educational courses worldwide, and has received Excellence in Teaching Awards on many occasions. He has been involved in guideline develop for the treatment of migraine and is involved in clinical research in migraine and has several publications.

    He is co-editor of Advanced Therapy of Headache and co-author of Headache Pocket Clinician 2010 from Cambridge University Press. In 2005 he received the Arnold P. Friedman Distinguished Clinician Research Award from the American Headache Society for outstanding contribution to the field of headache, and the 2007 Life Time Achievement Award from the Headache Cooperative of New England. He has been on the Editorial Board of Cephalalgia and is currently an Associate Editor for Headache.

    President - American Headache Society

Co-opted Trustees:

  • Mark Braschinsky (Estonia)
    Institution: Tartu University Hospital
    Country: Estonia

    Mark Braschinsky received his MD in medicine (in 2000), completed his residency in general neurology (in 2006) and his PhD in neurology (in 2010) at the Tartu University, Estonia. After training he became teaching neurologist and consultant at the Tartu University Clinics’ Department of Neurology, whereat he established a Headache Clinic in 2015. The same year he became a senior neurologist.

    Mark Braschinsky is founder and current president of Estonian Headache Society and board member of European Headache Federation. He is also a member of European Academy of Neurology’s Headache Scientific panel. His scientific work is related to clinical headache and pain research.


    Member of European Headache Federation Board of Directors (Council); President Estonian Headache Society; Speaker's honoraria: Abbott Laboratories SA, Allergan Inc, Berlin-Chemie AG (Menarini Group), Boehringer Ingelheim Pharma GmbH, Desitin Arzneimittel GmbH, EV3, Gedeon Richter Ltd, GlaxoSmithKline, H. Lundbeck A/S, Novartis Pharma Services Inc, Nycomed SEFA, Orion Pharma, Pfizer Inc, Sanofi-Aventis, Sandoz d.d., Scanmed Group, Solvay Pharmaceuticals, Zentiva International; Previously consultant for: H AbbePharma GmbH, Merz Pharmaceuticals

  • Chin-sang Chung (S Korea)
    Institution: Samsung Medical Center
    Country: S Korea

    Chin-Sang Chung has obtained his medical degree at the Seoul National University College of Medicine, Seoul, South Korea in 1981. He trained in neurology residency at the Seoul National University Hospital, Seoul, Korea. Afterwards he served as the neurology professor and chairman at the Chungnam National University College of Medicine, Daejeon, Korea. He obtained his PhD at the Seoul National University in 1989. Between 1992 and 1993 he did a research fellowship on stroke under the supervision of Dr. Louis R. Caplan, at the New England Medical Center of Tufts Medical School, Boston, MA, USA. In 1995 he moved to the Samsung Medical Center (SMC), Seoul, Korea as a neurology professor and also served as the department chair (2003-2009) and director of the Neuroscience Center (2009-2013). In addition to his major subspecialty of stroke, he established the first Headache Clinic in South Korea in 1995 and launched the Korean Headache Society (KHS) in 2001. And he served as the KHS president (2003-2007) and the vice-president of the Asian Headache Foundation (the president professor Fumihiko Sakai). Since October 2016, he has been the president of ARCH (Asian Regional Committee of Headache), which was originated from the Korean-Japanese Headache Congress that was launched by Chin-Sang Chung and Fumihiko Sakai in 2006. He is also the congress chairman of the Korean Stroke Society (KSS) after having served as the KSS president (2014-2016). He is actively involved in clinical researches on headache and stroke and has published 123 articles in SCI journals and wrote many book chapters on stroke and headache.


    Research support: Lilly, Otsuka

  • Bronwyn Jenkins (Australia)
    Institution: Sydney Adventist Hospital
    Country: Australia

    Dr Bronwyn Jenkins, BMed FRACP, is a consultant neurologist in Sydney, Australia. She graduated from The University of Newcastle in 1995. Dr Jenkins did a fellowship in Stroke at Royal North Shore Hospital but has later followed her interest in headache management. 

    Dr Jenkins was one of four delegates chosen to attend the International Headache Society Headache Master School in Tokyo, Japan in 2013. In 2018 she was an organiser for the 5th HMS in Sydney for Australian, New Zealand and neighbouring Asian delegates. 

    Dr Jenkins is interested in teaching students, trainees and colleagues, particularly about headache, being the lead author on the Headache Module for the Masters in Pain Management program at Sydney University. She continues to be involved in local advocacy for patients such as participating in consumer forums with Headache Australia.

    She is one of the founding members and Co-Secretary for the recently formed Australian and New Zealand Headache Society (ANZHS) which aims to improve management of headache patients in the Australian and New Zealand region. She is chair of the education and a member of the therapeutics and research subcommittees of ANZHS.

    Dr Jenkins is also a member of the Australian and New Zealand Association of Neurologists, International Headache Society and the International Association for the Study of Pain.


    Co-Secretary Australia and New Zealand Headache Society; Advisory board and lecture fees: Allergan, Lilly, Novartis and Teva. 

  • Ingela Nilsson Remahl (Sweden)
    Institution: Karolinska University Hospital Huddinge
    Country: Sweden

    Dr A Ingela M Nilsson Remahl is a senior neurologist since 1993 at the Neuro Theme, Karolinska University Hospital in Stockholm, Sweden.
    She graduated from Karolinska Institutet and wrote her thesis entitled An ultrastructural morphometric and reconstructive study on axons and Schwann cells in adult and developing lower lumbar ventral roots of the cat in 1987. She received her MD in 1993. Thereafter she turned to headache research and completed her residency in neurology in 1999. She participated in the first Headache Master School during 2000-2004. She participated in the International Headache Conference in Stockholm 2007. Dr Nilsson Remahl became associated professor in 2011 at the Karolinska Institutet.  She is a former vice head of the Department of Neurology at Karolinska University Hospital.
    Dr Nilsson Remahl is member of the Swedish Neurological Society and treasurer of the Swedish Headache Society. She is Head of the Headache Centre at Karolinska University Hospital. In November 2018 she will organize the first national course in headache disorders for a decade directed to young collegues to become neurologists.
    Member of the board in The Swedish Neurological Society and The Swedish Headache Society. Advisory board and lecture fees: Allergan. PI for studies on headaches: Allergan, Novartis and TEVA.


Trustee management documents are currently available.

Use your Trustee password to login and retrieve the documents.

If you are a Trustee and cannot remember the password please email Carol Taylor.

The content of the documents contained in this section is Confidential and
should not be disclosed to persons who are not IHS Trustees.



[DOC_CAT]Board Documents[/DOC_CAT]


You need to be a member of the IHS to access this area of the website, please sign in to continue.

To find out more about membership types and how to join the IHS click onto the 'join' banner on the home page.

Close this box to continue.

Access to the Members Directory is restricted to Standard IHS members

Members Login

Your membership is currently shown as unpaid.

To renew your membership online click HERE.

Otherwise, please contact Carol Taylor to discuss your renewal.

This document is only available to members – please login.